BR9701248A8 - compostos para a terapia de tumores e distérbios inflamatàrios, produto farmacÊutico e formulaÇço farmacÊutica dos mesmos - Google Patents
compostos para a terapia de tumores e distérbios inflamatàrios, produto farmacÊutico e formulaÇço farmacÊutica dos mesmosInfo
- Publication number
- BR9701248A8 BR9701248A8 BRPI9701248-3A8A BR9701248A BR9701248A8 BR 9701248 A8 BR9701248 A8 BR 9701248A8 BR 9701248 A BR9701248 A BR 9701248A BR 9701248 A8 BR9701248 A8 BR 9701248A8
- Authority
- BR
- Brazil
- Prior art keywords
- alkyl
- alkylamino
- glycosyl
- tumors
- therapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96103866 | 1996-03-12 |
Publications (3)
Publication Number | Publication Date |
---|---|
BR9701248A BR9701248A (pt) | 1999-10-13 |
BR9701248A8 true BR9701248A8 (pt) | 2013-06-18 |
BRPI9701248B1 BRPI9701248B1 (pt) | 2022-01-18 |
Family
ID=8222555
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI9701248A BRPI9701248B1 (pt) | 1996-03-12 | 1997-03-11 | Compostos para a terapia de tumores e distúrbios inflamatórios, produto farmacêutico e formulação farmacêutica dos mesmos |
Country Status (24)
Country | Link |
---|---|
US (1) | US5935995A (pt) |
EP (1) | EP0795334B1 (pt) |
JP (1) | JP4392065B2 (pt) |
KR (1) | KR100466467B1 (pt) |
CN (1) | CN1168733C (pt) |
AT (1) | ATE316799T1 (pt) |
AU (1) | AU708202B2 (pt) |
BG (1) | BG61900B1 (pt) |
BR (1) | BRPI9701248B1 (pt) |
CA (1) | CA2199664C (pt) |
CZ (1) | CZ297994B6 (pt) |
DE (1) | DE59712561D1 (pt) |
DK (1) | DK0795334T3 (pt) |
ES (1) | ES2257756T3 (pt) |
HU (1) | HU228764B1 (pt) |
NO (1) | NO320322B1 (pt) |
NZ (1) | NZ314368A (pt) |
PL (1) | PL189604B1 (pt) |
RO (1) | RO120951B1 (pt) |
RU (1) | RU2191021C2 (pt) |
SG (1) | SG50011A1 (pt) |
SI (1) | SI0795334T1 (pt) |
TR (1) | TR199700178A2 (pt) |
UA (1) | UA50719C2 (pt) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5525606A (en) | 1994-08-01 | 1996-06-11 | The United States Of America As Represented By The Department Of Health And Human Services | Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines |
DE19720312A1 (de) * | 1997-05-15 | 1998-11-19 | Hoechst Ag | Zubereitung mit erhöhter in vivo Verträglichkeit |
JP4812167B2 (ja) | 1999-02-12 | 2011-11-09 | モレキュラー インサイト ファーマスーティカルズ インコーポレイテッド | 薬物輸送用マトリックス、ならびにその作成方法および使用方法 |
US6716452B1 (en) | 2000-08-22 | 2004-04-06 | New River Pharmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
AU777770C (en) | 1999-05-04 | 2005-11-10 | Strakan International Limited | Androgen glycosides and androgenic activity thereof |
US6191119B1 (en) * | 1999-10-15 | 2001-02-20 | Supergen, Inc. | Combination therapy including 9-nitro-20(S)-camptothecin |
US8394813B2 (en) | 2000-11-14 | 2013-03-12 | Shire Llc | Active agent delivery systems and methods for protecting and administering active agents |
DE10058596A1 (de) * | 2000-11-25 | 2002-06-06 | Aventis Pharma Gmbh | Verfahren zum Screening von chemischen Verbindungen zur Modulierung der Wechselwirkung einer EVH1-Domäne oder eines Proteins mit einer EVH1-Domäne mit einer EVH1-Bindedomäne oder einem Protein mit einer EVH1-Bindedomäne sowie ein Verfahren zum Nachweis besagter Wechselwirkung |
US7169752B2 (en) | 2003-09-30 | 2007-01-30 | New River Pharmaceuticals Inc. | Compounds and compositions for prevention of overdose of oxycodone |
US20060014697A1 (en) | 2001-08-22 | 2006-01-19 | Travis Mickle | Pharmaceutical compositions for prevention of overdose or abuse |
ATE439131T1 (de) | 2001-08-30 | 2009-08-15 | Chemocentryx Inc | Bicyclische verbindungen als hemmer der chemokin- bindung an us28 |
AU2003244088A1 (en) * | 2002-06-20 | 2004-01-06 | Nippon Suisan Kaisha, Ltd. | Produrg, medicinal utilization thereof and process for producing the same |
US8133881B2 (en) | 2003-01-13 | 2012-03-13 | Shire Llc | Carbohydrate conjugates to prevent abuse of controlled substances |
US7160867B2 (en) * | 2003-05-16 | 2007-01-09 | Isotechnika, Inc. | Rapamycin carbohydrate derivatives |
JP2007530664A (ja) * | 2004-03-30 | 2007-11-01 | ペインセプター ファーマ コーポレーション | ゲートイオンチャンネルを調節するための組成物及び方法 |
US7825096B2 (en) * | 2004-09-08 | 2010-11-02 | The United States Of America As Represented By The Department Of Health And Human Services | O6-alkylguanine-DNA alkyltransferase inactivators and beta-glucuronidase cleavable prodrugs |
PT2155682E (pt) * | 2007-04-06 | 2015-10-15 | Ziopharm Oncology Inc | Sais de mostarda de isofosforamida e análogos da mesma |
GB0907551D0 (en) * | 2009-05-01 | 2009-06-10 | Univ Dundee | Treatment or prophylaxis of proliferative conditions |
EP2473509A4 (en) * | 2009-09-02 | 2013-04-17 | Auckland Uniservices Ltd | KINASEHEMMER, PRODRUG-FORMS THEREOF AND ITS USE IN THERAPY |
KR101253399B1 (ko) | 2010-10-26 | 2013-04-11 | 영남대학교 산학협력단 | 아포지단백질 a-i 및 그 변이체를 포함한 재조합 고밀도지단백질을 이용한 라파마이신 제형 |
KR101628872B1 (ko) * | 2014-05-28 | 2016-06-09 | 주식회사 레고켐 바이오사이언스 | 자가-희생 기를 포함하는 화합물 |
KR20180079452A (ko) | 2015-11-25 | 2018-07-10 | 주식회사 레고켐 바이오사이언스 | 자기-희생기를 포함하는 접합체 및 이의 제조방법 |
AU2016359234B2 (en) | 2015-11-25 | 2022-09-08 | Legochem Biosciences, Inc. | Conjugates comprising peptide groups and methods related thereto |
CN113599533A (zh) | 2015-11-25 | 2021-11-05 | 乐高化学生物科学股份有限公司 | 包含分支接头的抗体-药物缀合物及其相关方法 |
AU2016363013B2 (en) | 2015-12-04 | 2022-03-10 | Seagen Inc. | Conjugates of quaternized tubulysin compounds |
US11793880B2 (en) | 2015-12-04 | 2023-10-24 | Seagen Inc. | Conjugates of quaternized tubulysin compounds |
AU2018246806B2 (en) | 2017-03-29 | 2022-05-12 | Legochem Biosciences, Inc. | Pyrrolobenzodiazepine dimer precursor and ligand-linker conjugate compound thereof |
AU2019216531A1 (en) | 2018-02-02 | 2020-09-24 | Maverix Oncology, Inc. | Small molecule drug conjugates of gemcitabine monophosphate |
JP7459063B2 (ja) | 2018-05-09 | 2024-04-01 | レゴケム バイオサイエンシズ, インク. | 抗-cd19抗体薬物複合体に関連する組成物および方法 |
KR20210028544A (ko) | 2019-09-04 | 2021-03-12 | 주식회사 레고켐 바이오사이언스 | 인간 ror1에 대한 항체를 포함하는 항체 약물 접합체 및 이의 용도 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5284856A (en) * | 1988-10-28 | 1994-02-08 | Hoechst Aktiengesellschaft | Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives |
DE3836676A1 (de) * | 1988-10-28 | 1990-05-03 | Hoechst Ag | Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel |
DE69019959T2 (de) * | 1989-01-23 | 1995-10-05 | Akzo Nobel Nv | Ortspezifische in-vivo-aktivierung von therapeutischen arzneimitteln. |
DE4106389A1 (de) * | 1991-02-28 | 1992-09-03 | Behringwerke Ag | Fusionsproteine zur prodrug-aktivierung, ihre herstellung und verwendung |
KR100188801B1 (ko) * | 1990-05-18 | 1999-06-01 | 엥겔하르트 라피체 | 이속사졸-4카복스아미드 및 하이드록시알킬리덴 시아노아세트아미드 및 이들 화합물을 함유하는 약제학적 조성물 |
FR2676058B1 (fr) * | 1991-04-30 | 1994-02-25 | Hoechst Lab | Prodrogues glycosylees, leur procede de preparation et leur utilisation dans le traitement des cancers. |
EP0538799B1 (en) * | 1991-10-25 | 1995-03-15 | TUNGSRAM Részvénytársaság | Single-capped low-pressure discharge lamp |
DE4233152A1 (de) * | 1992-10-02 | 1994-04-07 | Behringwerke Ag | Antikörper-Enzym-Konjugate zur Prodrug-Aktivierung |
CA2081281A1 (en) * | 1992-10-23 | 1994-04-24 | Shing-Ming Wang | Activation of glucuronide prodrugs by ligand-beta-glucuronidase conjugates for chemotherapy |
DE4236237A1 (de) * | 1992-10-27 | 1994-04-28 | Behringwerke Ag | Prodrugs, ihre Herstellung und Verwendung als Arzneimittel |
DE4314556A1 (de) * | 1993-05-04 | 1994-11-10 | Behringwerke Ag | Modifizierte Antikörperenzymkonjugate und Fusionsproteine sowie ihre Anwendung zur tumorselektiven Therapie |
EP0647450A1 (en) * | 1993-09-09 | 1995-04-12 | BEHRINGWERKE Aktiengesellschaft | Improved prodrugs for enzyme mediated activation |
DE4417865A1 (de) * | 1994-05-20 | 1995-11-23 | Behringwerke Ag | Kombination von Tumornekrose-induzierenden Substanzen mit Substanzen, die durch Nekrosen aktiviert werden, zur selektiven Tumortherapie |
-
1997
- 1997-02-27 SI SI9730727T patent/SI0795334T1/sl unknown
- 1997-02-27 AT AT97103162T patent/ATE316799T1/de active
- 1997-02-27 EP EP97103162A patent/EP0795334B1/de not_active Expired - Lifetime
- 1997-02-27 ES ES97103162T patent/ES2257756T3/es not_active Expired - Lifetime
- 1997-02-27 DK DK97103162T patent/DK0795334T3/da active
- 1997-02-27 DE DE59712561T patent/DE59712561D1/de not_active Expired - Lifetime
- 1997-03-03 RO RO97-00402A patent/RO120951B1/ro unknown
- 1997-03-06 RU RU97103585/14A patent/RU2191021C2/ru not_active IP Right Cessation
- 1997-03-06 BG BG101290A patent/BG61900B1/bg unknown
- 1997-03-07 AU AU16205/97A patent/AU708202B2/en not_active Ceased
- 1997-03-10 PL PL97318878A patent/PL189604B1/pl unknown
- 1997-03-10 TR TR97/00178A patent/TR199700178A2/xx unknown
- 1997-03-10 NZ NZ314368A patent/NZ314368A/xx not_active IP Right Cessation
- 1997-03-11 BR BRPI9701248A patent/BRPI9701248B1/pt not_active IP Right Cessation
- 1997-03-11 US US08/814,655 patent/US5935995A/en not_active Expired - Lifetime
- 1997-03-11 JP JP05598397A patent/JP4392065B2/ja not_active Expired - Fee Related
- 1997-03-11 CN CNB971034656A patent/CN1168733C/zh not_active Expired - Fee Related
- 1997-03-11 CA CA002199664A patent/CA2199664C/en not_active Expired - Fee Related
- 1997-03-11 NO NO19971116A patent/NO320322B1/no not_active IP Right Cessation
- 1997-03-11 UA UA97031095A patent/UA50719C2/uk unknown
- 1997-03-11 CZ CZ0074297A patent/CZ297994B6/cs not_active IP Right Cessation
- 1997-03-12 SG SG1997000702A patent/SG50011A1/en unknown
- 1997-03-12 KR KR1019970008174A patent/KR100466467B1/ko not_active IP Right Cessation
- 1997-03-12 HU HU9700579A patent/HU228764B1/hu not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9701248A8 (pt) | compostos para a terapia de tumores e distérbios inflamatàrios, produto farmacÊutico e formulaÇço farmacÊutica dos mesmos | |
DE10075007I2 (de) | 1,4,7,10-Tetraazacyclododecan-butyltriole Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel | |
ATE175201T1 (de) | Mono-n-substituierte 1,4,7,10- tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel | |
HUP0303347A2 (hu) | (R)-2-aril-propionsav-omega-aminoalkilamidok mint polimorf magvú és egymagvú sejtek kemotaxisának inhibitorai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
DE3576690D1 (de) | Pyrimidopyrimidinderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische zubereitungen und ihre verwendung als anti-allergische mittel. | |
ES530901A0 (es) | Procedimiento para preparar derivados de piperazina | |
NO20015172L (no) | 1-metyl-erytromycin-derivater | |
RU93005057A (ru) | Фармацевтические соединения, производные тиенобензодиазепина, способ их получения, фармкомпозиция и их использование | |
ATE252369T1 (de) | Konservierungssysteme fur cyclodextrine enthaltende arzneimittel | |
SE9603283D0 (sv) | New compounds | |
DE68913762T2 (de) | Diarylverbindungen als antiatherosklerotische Mittel. | |
BR1100061A (pt) | Composto, processo para a preparação do mesmo, composição e uso dos mesmos | |
ATE97901T1 (de) | Cephalosporinderivate, verfahren zu ihrer herstellung sowie entsprechende pharmazeutische praeparate. | |
KR900017994A (ko) | 사이클로알킬-치환된 글루타르아미드 이뇨제 | |
HUP0103316A2 (hu) | 2-Ureido-pirimidon-származékok, eljárás azok előállítására, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk | |
ATE188217T1 (de) | 1,2,3,4,10,14b-hexahydrodibenzo-c,f)pyrazino-1, - a)azepino-derivate | |
DE69803894T2 (de) | Heterozyclische Verbindungen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen | |
FI913713A0 (fi) | Nya bicykliska aminosubstituerade foereningar. | |
ATE281452T1 (de) | 4-amino-2-ureido-pyrimidin-5-carbonsäureamide, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung | |
DE69901088D1 (de) | 1,2-Dithiolan Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen | |
DE68905361D1 (de) | Trienische derivate mit chromenischer struktur, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen. | |
PT99207A (pt) | Processo de preparacao de derivados da piperidina e de composicoes farmaceuticas | |
DE59712054D1 (de) | 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung | |
DK0687257T3 (da) | 4-amino-2-(hetero)aryl-butanamider anvendelige som 5HT1A-antagonister | |
GR3021761T3 (en) | Leukotriene-b 4? derivatives, process for preparing the same and medicaments. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Transfer |
Free format text: AVENTIS PHARMA DEUSTSCHLAND GMBH (DE) |
|
HHT | Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: republication |
Free format text: TRANSFERIDO DE: HOECHST AKTIENGESELLSCHAFT - REFERENCIA RPI NO. 1587 DE 05/06/2001 COD. 25.1 - ITEM71 |
|
B25D | Requested change of name of applicant approved |
Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) Free format text: ALTERADO DE: AVENTIS PHARMA DEUTSCHLAND GMBH |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B11D | Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time | ||
B11N | Dismissal: publication cancelled [chapter 11.14 patent gazette] |
Free format text: PUBLICACAO ANULADA REFERENTE RPI 2209 DE 07/05/2013.POR TER SIDO INDEVIDA. |
|
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 18/06/2013, OBSERVADAS AS CONDICOES LEGAIS. |
|
B03H | Publication of an application: rectification [chapter 3.8 patent gazette] |
Free format text: REFERENTE A RPI 1501 DE 13/10/1999, QUANTO AO ITEM (30 E 72), CONFORME SOLICITADO NA PETICAO NO18504/RJ DE 25/08/1997. |
|
B22O | Other matters related to patents and certificates of addition of invention: legal action concerning patent |
Free format text: INPI-52400.061553/2013 ORIGEM: JUIZO DA 013A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO 0132273-17.2013.4.02.5101 ACAO DE NULIDADE DAS PATENTES SUBMETIDAS AO MAILBOX (ART. 229, PARAGRAFO UNICO DA LPI); ALTERNATIVAMENTE, A DECRETACAO DA NULIDADE PARCIAL PARA CORRECAO DO PRAZO DE VIGENCIA; SUBSIDIARIAMENTE, CASO SE ENTENDA NAO SER O CASO DE NULIDADE, A CORRECAO DO ATO ADMINISTRATIVO PARA ADEQUACAO DA VIGENCIA DAS PATENTES. AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU:OSI PHARMACEUTICALS, LLC , PFIZER, SANOFI-AVERTI, , SANOFI-AVERTI DEUTCHLAND GMBH, SCHERING CORPORATION. |
|
B15K | Others concerning applications: alteration of classification |
Ipc: A61K 47/54 (2017.01) |
|
B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 11/03/2017, CONFORME DETERMINADO NO INPI-52400.061553/2013-52 SECAO JUDICIARIA DO RIO DE JANEIRO 9A VARA FEDERAL DO RIO DE JANEIRO PROCESSO : NO 0132273-17.2013.4.02.5101. |
|
B21H | Decision of lapse of a patent or of a certificate of addition of invention cancelled [chapter 21.8 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 21.1 NA RPI NO 2543 DE 01/10/2019 POR TER SIDO INDEVIDA. |
|
B19A | Notification of judicial decision: notification of judicial decision |
Free format text: INPI NO 52402.005802/2020-39 TRIBUNAL REGIONAL FEDERAL DA 2A REGIAO PROCESSO : NO 5004917-81.2020.4.02.0000/RJ REQUERENTE: MERCK SHARP AND DOHME CORPORATION REQUERENTE: PFIZER PRODUCTS REQUERENTE: OSI PHARMACEUTICALS, LLC. REQUERIDO: INPI-INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL MPF: MINISTERIO PUBLICO FEDERAL AMICUS CURIAE: ASSOCIACAO BRAS DAS IND DE Q FINA B E SUAS ESP ABIFINA AMICUS CURIAE: INTERFARMA ASSOCIACAO DA INDUSTRIA FARMACEUTICA DE PESQUISA INTERESSADO: SANOFI-AVENTIS DEUTSCHLAND GMBM INTERESSADO: SANOFI AVENTIS INTERESSADO: ZOETIS LLC DECISAO: ANTE O EXPOSTO, ATRIBUO EFEITO SUSPENSIVO A APELACAO INTERPOSTA NO PROCESSO NO 0132273-17.2013.4.02.5101 POR OSI PHARMA |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/03/1997, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |